Electrophysiology devices are cardiac specialty equipments which are used in the diagnosis and treatment of cardiac arrhythmias. An electrophysiology test is used to evaluate heart’s electrical system and to check abnormal heart rhythms. Electrophysiologic testing uses catheters inserted into the heart to find out where abnormal heartbeats are coming from. While performing electrophtsiology test a thin tube called a catheter is inserted into blood vessel that reaches to heart. Then specialized electrodes are placed in the heart to send electrical signals and measure electrical activity in heart. Electrophysiology test is used to see te risk of heart problems such as fainting or sudden cardiac death due to cardiac arrest and also to treat a problem by destroying the place inside heart that is causing the abnormal electrical signal. This procedure is called catheter ablation. Electrophysiology study can help to determine the cause of irregular heart rhythms (arrhythmias) and to predict the risk of sudden cardiac death. As with many tests and procedure, electrophysiology study has some risks such as bleeding around the heart caused by damage to the heart tissue , blood clots in the lungs or legs, etc.
Market Dynamics
Increasing adoption of inorganic strategies such as product launches by key market players is expected to drive the global electrophysiology devices market growth over the forecast period. For instance, in October 2020, Medtronic, a medical device company, announced that they had launched Azure pacemaker with BlueSync technology. A pacemaker that can communicate directly with patients’ smartphones and tablets, which is designed to detect and reduce the likelihood of atrial fibrillation.
Key features of the study:
- This report provides an in-depth analysis of the global electrophysiology devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global electrophysiology devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include General Electric Company, Biotricity, Medtronic, VivaQuant, Inc., Johnson & Johnson Services, Inc., AliveCor, Inc., Bittium, Nihon Kohden Corporation, Shimmer, OMRON Healthcare, Co., Ltd., VivaLNK, Inc., Abbott, BIOTRONIK, Boston Scientific Corporation, MicroPort Scientific Corporation, Koninklijke Philips N.V., Siemens Healthcare GmbH, HeartSciences, anumana, Inc., and Omega Medical Imaging, LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global electrophysiology devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electrophysiology devices market
Detailed Segmentation:
- Global Electrophysiology Devices Market, By Product Type:
- Electrophysiology Monitoring Devices
- Electrocardiograph
- Holter Monitoring Devices
- X-Ray Systems
- Combo systems - Imaging and 3D mapping systems
- Diagnostic Electrophysiology Catheters
- Electrophysiology Treatment Devices
- Implantable Cardioveter Defibrillators
- Pacemakers
- Cardiac Resynchronization Therapy Devices
- Catheters
- Global Electrophysiology Devices Market, By Indication:
- Atrial Fibrillation
- Atrioventricular Nodal Re-entry Tachycardia
- Supraventricular Tachycardia
- Bradycardia
- Others (Wolff-Parkinson-White Syndrome, etc.)
- Global Electrophysiology Devices Market, By End User:
- Hospitals
- Diagnostic Centers
- Clinics
- Others (Ambulatory Surgical Centers, etc.)
- Global Electrophysiology Devices Market, By Region:
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Regions
- South Africa
- Central Africa
- North Africa
- Company Profiles
- General Electric Company *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biotricity
- Medtronic
- VivaQuant, Inc.
- Johnson & Johnson Services, Inc.
- AliveCor, Inc.
- Bittium
- Nihon Kohden Corporation
- Shimmer
- OMRON Healthcare, Co., Ltd.
- VivaLNK, Inc.
- Abbott
- BIOTRONIK
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Koninklijke Philips N.V.
- Siemens Healthcare GmbH
- HeartSciences
- anumana, Inc.
- Omega Medical Imaging, LLC.
“*” marked represents similar segmentation in other categories in the respective section.
